JENNIFER SMITH: Open Payments
NPI 1023408291 · BYRON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 42 payments from 10 companies in 2025. Trend: 2023 $722 · 2024 $1,332 · 2025 $1,475
Food & beverage: $1,475
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $423 |
| Novo Nordisk Inc | 8 | $361 |
| ABBVIE INC. | 9 | $358 |
| Lilly USA, LLC | 5 | $96 |
| Abbott Laboratories | 5 | $91 |
| Dexcom, Inc. | 4 | $65 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, VRAYLAR, Wegovy, AIRSUPRA, QULIPTA, MOUNJARO, FREESTYLE LIBRE 3, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
